Canntab Receives Medical Sales Licence from Health Canada
Ryan Allway November 11th, 2021 TORONTO, Nov. 11, 2021 /CNW/ – Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab”), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has received its medical sales license from Health Canada... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )